U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea
· Delayed Price · Currency is KRW 5,140.00
-350.00 (-6.38%)
At close: Dec 5, 2025
U2Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
| Net Income | -2,986 | -2,840 | 645.9 | 13,160 | 271.68 | 136.76 |
| Depreciation & Amortization | 770.04 | 877.21 | 918.87 | 887.97 | 231.75 | 197.52 |
| Loss (Gain) From Sale of Assets | - | - | -6.21 | 71.54 | - | - |
| Asset Writedown & Restructuring Costs | 25.46 | -13.64 | 51.69 | 22.7 | - | - |
| Provision & Write-off of Bad Debts | 213.66 | 14.99 | 242.13 | 64.81 | - | - |
| Other Operating Activities | 1,967 | 1,466 | -2,765 | 2,961 | 578.39 | 401.96 |
| Change in Accounts Receivable | -371.8 | 401.31 | 2,393 | 11,746 | -2,019 | -2,492 |
| Change in Inventory | 118.53 | 55.22 | -87.22 | -74.1 | 104.44 | 169.24 |
| Change in Accounts Payable | -87.51 | -980.22 | -945.32 | -3,934 | 55.57 | 1,141 |
| Change in Other Net Operating Assets | -284.03 | -712.05 | -3,002 | -499.46 | -209.08 | 142.8 |
| Operating Cash Flow | -634.3 | -1,731 | -2,555 | 24,406 | -986.6 | -303.3 |
| Capital Expenditures | -13.44 | -43.39 | -214.43 | -967.1 | -495.43 | -32.1 |
| Sale (Purchase) of Intangibles | -69.09 | -310.08 | -618 | -175 | -213.93 | - |
| Investment in Securities | -14,907 | -16,000 | 33,987 | -35,478 | -75 | - |
| Other Investing Activities | 0.72 | 20.72 | 50 | -66.72 | -34.26 | 4.3 |
| Investing Cash Flow | -14,960 | -16,333 | 33,205 | -36,686 | -840.28 | -5.48 |
| Short-Term Debt Issued | - | - | - | - | 1,650 | 179 |
| Long-Term Debt Issued | - | - | - | - | 600 | 200 |
| Total Debt Issued | - | - | - | - | 2,250 | 379 |
| Short-Term Debt Repaid | - | - | - | -700 | -1,715 | -10 |
| Long-Term Debt Repaid | - | -398.64 | -418.8 | -1,314 | - | - |
| Total Debt Repaid | -380.16 | -398.64 | -418.8 | -2,014 | -1,715 | -10 |
| Net Debt Issued (Repaid) | -380.16 | -398.64 | -418.8 | -2,014 | 535 | 369 |
| Issuance of Common Stock | - | - | 5,215 | - | 2,000 | - |
| Dividends Paid | - | -338.62 | -1,263 | -757.65 | - | - |
| Other Financing Activities | - | - | -325.66 | - | - | - |
| Financing Cash Flow | -380.16 | -737.26 | 3,207 | -2,771 | 2,535 | 369 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - |
| Net Cash Flow | -15,974 | -18,801 | 33,858 | -15,052 | 708.12 | 60.22 |
| Free Cash Flow | -647.74 | -1,775 | -2,769 | 23,439 | -1,482 | -335.41 |
| Free Cash Flow Margin | -2.53% | -7.09% | -8.99% | 33.96% | -13.47% | -3.56% |
| Free Cash Flow Per Share | -57.50 | -157.22 | -270.09 | 2320.73 | -1025.56 | -284.50 |
| Cash Interest Paid | 70.67 | 42.62 | 36.32 | 38.44 | - | - |
| Cash Income Tax Paid | 62.86 | -75.08 | 2,890 | 190.19 | - | - |
| Levered Free Cash Flow | -3,811 | -2,709 | -4,676 | - | -1,962 | - |
| Unlevered Free Cash Flow | -3,786 | -2,682 | -4,653 | - | -1,728 | - |
| Change in Working Capital | -624.81 | -1,236 | -1,641 | 7,238 | -2,068 | -1,040 |
Source: S&P Capital IQ. Standard template. Financial Sources.